Today is July 31, 2024. All times in Eastern Daylight Time.
Pint Pharma anuncia la aprobación de ORLADEYO® (berotralstat), la primera terapia oral indicada para prevenir los ataques de angioedema hereditario (HAE) en pacientes adultos y pediátricos de 12 años en adelante en Peru.
07/08/2024 - 06:34 PM
BUSINESS WIRE
Launch and Celebration of the AIATSIS Centre for Australian Languages
07/08/2024 - 06:30 PM
BUSINESS WIRE
Manh Choh Mine Pours First Gold
07/08/2024 - 06:16 PM
BUSINESS WIRE
Taiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia
07/08/2024 - 06:00 PM
BUSINESS WIRE
American Express Declares Dividend on Series D Preferred Stock
07/08/2024 - 05:47 PM
BUSINESS WIRE
CareAtHome Medical Group, Partnering with Vesta Healthcare, Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
07/08/2024 - 05:37 PM
BUSINESS WIRE
Capstone Copper to Release Second Quarter Results on August 1, 2024
07/08/2024 - 05:30 PM
BUSINESS WIRE
KBRA Affirms Ratings for Banner Corporation
07/08/2024 - 05:30 PM
BUSINESS WIRE
Moody's acquiert entièrement GCR Ratings, intensifiant ainsi sa présence sur les marchés nationaux du crédit en Afrique
07/08/2024 - 05:24 PM
BUSINESS WIRE
AutoLeap Accelerates Ahead: Earns 5 Badges in G2 Summer Report
07/08/2024 - 05:20 PM
BUSINESS WIRE
1
...
1204
1205
1206
1207
1208
1209
1210
1211
1212
1213
1214
...
1483
« Previous
Next »